CD73, an enzyme involved in the production of immunosuppressive adenosine, contributed to the creation of an immunosuppressive tumor microenvironment and promoted the survival of melanoma cells under the stress of BRAFi treatment. The gene discussed is NT5E; the disease is neoplasm.